<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Medical devices (MD), together with pharmacotherapy are supportive treatment of many acute and chronic diseases. MD as a part
of medical technologies lead to more effective treatment, faster patient recovery and a reduced risk of complications. Many MD
are reimbursed from public health insurance funds entirely; for others, particularly advanced functional types of MD, there must
be patient participation on price or they can buy them according own decision (direct sale). The target of this study is to analyze
the data from paid databases of National Center for Health Information (NCHI) that collects the outputs of provided healthcare.
The most recent data were from 1.1.2013 to 30.9.2013. According to NCHI, apart from community pharmacies, there are 226
registered establishments that sold MD until 30.9.2013. Their specialization included dispensing MD (n=163), dispensing orthopaedic
devices (n=48) and dispensing audioprosthetic devices (n=15). In the observed period, average monthly spending on
MD were 10.1 million packages and 14 million €. Average monthly spending on reimbursed MD were 8.8 million packages and
12.9 million €. The groups with the largest shares were MD for incontinence and urinary retention, 7.7 million packages (86.9%)
and 3.9 million € (30.7%); plasters and bandaging materials, 0.5 million packages (6.0%) and 1.3 million € (10.1%); MD for ostomies,
0.4 million packages (4.5%) and 1 million € (8.0%); and the MD for diabetics group, 0.1 million packages (1.4%) and 1.6 million €
(12.8%). Direct sales of MD per month on average reached 1.3 million packages and 1.1 million €. The groups with largest shares
were MD for incontinence and urinary retention, 629,660 packages (50.3%) and 291,919 € (26.2%); plasters and bandaging materials,
388,111 packages (31.0%) and 227,119 € (20.4%); and MD for diabetics, 56,014 packages (4.5%) and 81,721 € (7.3%).</p></abstract>

Medical devices (MD), together with pharmacotherapy are supportive treatment of many acute and chronic diseases. MD as a part
of medical technologies lead to more effective treatment, faster patient recovery and a reduced risk of complications. Many MD
are reimbursed from public health insurance funds entirely; for others, particularly advanced functional types of MD, there must
be patient participation on price or they can buy them according own decision (direct sale). The target of this study is to analyze
the data from paid databases of National Center for Health Information (NCHI) that collects the outputs of provided healthcare.
The most recent data were from 1.1.2013 to 30.9.2013. According to NCHI, apart from community pharmacies, there are 226
registered establishments that sold MD until 30.9.2013. Their specialization included dispensing MD (n=163), dispensing orthopaedic
devices (n=48) and dispensing audioprosthetic devices (n=15). In the observed period, average monthly spending on
MD were 10.1 million packages and 14 million €. Average monthly spending on reimbursed MD were 8.8 million packages and
12.9 million €. The groups with the largest shares were MD for incontinence and urinary retention, 7.7 million packages (86.9%)
and 3.9 million € (30.7%); plasters and bandaging materials, 0.5 million packages (6.0%) and 1.3 million € (10.1%); MD for ostomies,
0.4 million packages (4.5%) and 1 million € (8.0%); and the MD for diabetics group, 0.1 million packages (1.4%) and 1.6 million €
(12.8%). Direct sales of MD per month on average reached 1.3 million packages and 1.1 million €. The groups with largest shares
were MD for incontinence and urinary retention, 629,660 packages (50.3%) and 291,919 € (26.2%); plasters and bandaging materials,
388,111 packages (31.0%) and 227,119 € (20.4%); and MD for diabetics, 56,014 packages (4.5%) and 81,721 € (7.3%).

Spending of medical devices in Slovakia

Comenius University in Bratislava, Faculty of Pharmacy,
Department of Organisation and Management in Pharmacy,
Bratislava, Slovak republic

European Pharmaceutical Journal

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"Spending of medical devices in Slovakia"}

Medical devices (MD), together with pharmacotherapy are supportive treatment of many acute and chronic diseases. MD as a part
of medical technologies lead to...

Spending of medical devices in Slovakia

Data publikacji: 30 gru 2014

Zakres stron: 35 - 41

DOI: https://doi.org/10.2478/afpuc-2014-0009

Słowa kluczowe
medical devices, spending of medical devices, reimbursed medical devices, direct sale of medical devices, groups of medical devices, effective treatment, cost savings

© Acta Facultatis Pharmaceuticae Universitatis Comenianae

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Spending of medical devices in Slovakia

Data publikacji: 30 gru 2014

Zakres stron: 35 - 41

DOI: https://doi.org/10.2478/afpuc-2014-0009

Słowa kluczowemedical devices, spending of medical devices, reimbursed medical devices, direct sale of medical devices, groups of medical devices, effective treatment, cost savings

© Acta Facultatis Pharmaceuticae Universitatis Comenianae

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Słowa kluczowe
medical devices, spending of medical devices, reimbursed medical devices, direct sale of medical devices, groups of medical devices, effective treatment, cost savings